The role of mast cells in atopy: What can we learn from canine models? A thorough review of the biology of mast cells in canine and human systems

British Journal of Dermatology

Volumn 155, Issue 6, 2006, Pages 1109-1123

  De Mora, F ^a   Puigdemont, A ^a   Torres, R ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Atopy; Canine; Human; Mast cells

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CETIRIZINE; CONCANAVALIN A; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; KETOTIFEN; LORATADINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM; TERFENADINE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ALLERGIC ASTHMA; ALLERGY TEST; ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; ATOPY; CELL ISOLATION; CELL POPULATION; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CORTICOSTEROID THERAPY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; HISTAMINE RELEASE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MAST CELL; MASTOCYTOMA; NONHUMAN; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; REVIEW; SIGNAL TRANSDUCTION; SKIN ALLERGY; SKIN SENSITIZATION; STRUCTURAL HOMOLOGY; TH1 CELL; TH2 CELL;

ANIMALS; DOGS; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MAST CELLS; MODELS, BIOLOGICAL; PHENOTYPE;

EID: 33750924624     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07494.x     Document Type: Review

References (247)

1. Galli SJ, Costa JJ. Mast-cell-leukocyte cytokine cascades in allergic inflammation. Allergy 1995; 50:851-62.
2. Galli SJ. The mast cell: a versatile effector cell for a challenging world. Int Arch Allergy Immunol 1997; 113:14-22.
3. Church MK, Benyon RC, Lowman MA et al. Allergy or inflammation? From neuropeptide stimulation of human skin mast cells to studies on the mechanism of the late asthmatic response. Agents Actions 1989; 26:22-30.
4. Enerbäck L. The differentiation and maturation of inflammatory cells involved in the allergic response: mast cells and basophils. Allergy 1997; 52:4-10.
5. Irani AM, Sampson HA, Schwartz LB. Mast cells in atopic dermatitis. Allergy 1989; 44:31-4.
6. Levi-Schaffer F, Shalit M. Long-term cultures of mast cells: a new model for studying the allergic response. Pharmacol Res 1991; 24:307-17.
7. Holgate ST, Robinson C, Church MK. Mediators of immediate hypersensitivity. In: Allergy: Principles and Practice (Middleton E Jr, ed.). St Louis: Mosby, 1993; 267-301.
8. Mackay IS, Durham SR. The classification and diagnosis of rhinitis. In: Allergy and Allergic Diseases (Kay AB, ed.), Vol. 2. Oxford: Blackwell Science, 1997; 1293-9.
9. Fabbri LM, Caramori G, Maestrelli P. Definition, clinical features, investigations and differential diagnosis of asthma. In: Allergy and Allergic Diseases (Kay AB, ed.), Vol. 2. Oxford: Blackwell Science, 1997; 1347-59.
10. Bruijinzeel-Koomen CAFM, Muddle GC, Kapp A. Atopic dermatitis. In: Allergy and Allergic Diseases (Kay AB, ed.), Vol. 2. Oxford: Blackwell Science, 1997; 1573-85.
11. Drazen JM, Evans JF, Stevens RL, Shipp MA. Inflammatory effector mechanisms in asthma. Am J Crit Care Med 1995; 152:403-7.
12. Bumbacea D, Campbell D, Nguyen L et al. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004; 24:122-8.
13. Antunez C, Torres MJ, Mayorga C et al. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T cells from patients with acute or chronic atopic dermatitis. Clin Exp Allergy 2004; 34:559-66.
14. MacLeod JDA, Anderson DF, Baddeley SM et al. Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva. Clin Exp Allergy 1997; 27:1328-34.
15. Agis H, Fureder W, Bankl HC et al. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 1996; 87:535-43.
16. Anderson WH, Davidson TM, Broide DH. Mast cell TNF mRNA expression in nasal mucosa demonstrated by in situ hybridization: a comparison of mast cell detection methods. J Immunol Methods 1996; 189:145-55.
17. Bradding P, Okayama Y, Howarth PH et al. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995; 155:297-307.
18. Williams CM, Galli SJ. The diverse potential effector and immunoregulatory roles of mast cells in allergic diseases. J Allergy Clin Immunol 2000; 192:455-62.
19. Christofidou-Solomidou M, Murphy JF, Albelda SM. Induction of E-selectin dependent leukocyte recruitment by mast cell degranulation in human skin grafts transplanted on SCID mice. Am J Pathol 1996; 148:177-88.
20. Leon A, Buriani A, Dal Toso R et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994; 91:3739-43.
21. Moller A, Lippert U, Lessmann D et al. Human mast cells produce IL-8. J Immunol 1993; 151:3261-6.
22. Ohkawara Y, Yamauchi K, Tanno Y et al. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-α in sensitized lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol 1992; 7:385-92.
23. Okayama Y, Petit-Frere C, Kassel O et al. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol 1995; 155:1796-808.
24. Okayama Y, Bradding P, Tunon-de-Lara JM et al. Cytokine production by human mast cells. Human basophils and mast cells: biological aspects. Chem Immunol 1995; 61:114-34.
25. Schleimer RP, MacGlashan DW Jr, Peters SP et al. Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis 1986; 133:614-17.
26. Sillaber C, Bevec D, Butterfield JH et al. Tumor necrosis factor α and interleukin-1β mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. Exp Hematol 1993; 21:1271-5.
27. Drazen JM, Arm JP, Austen KF. Sorting out the cytokines of asthma. J Exp Med 1996; 183:1-5.
28. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990; 11:458-64.
29. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5, and -6 and tumor necrosis factor-a in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
30. Baskar S, Hamilton RG, Norman PS, Ansari AA. Grass immunotherapy induces inhibition of allergen-specific human peripheral blood mononuclear cell proliferation. Int Arch Allergy Immunol 1997; 112:184-90.
31. Demoly P, Simony-Lafontaine J, Chanez P et al. Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am J Crit Care Med 1994; 150:214-17.
32. Djukanovic R, Wilson JW, Britten KM et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142:863-71.
33. Ebisawa M, Shichijo M, Miura K et al. Human mast cells produce TNFa, MIP-1a and IL-5 following activation through FceRI. J Allergy Clin Immunol 1995; 95:219-314.
34. Fukuda T, Nakajima H, Fukushima Y et al. Detection of interleukin-5 messenger RNA and interleukin-5 protein in bronchial biopsies from asthma by nonradioactive in situ hybridization and immunohistochemistry. J Allergy Clin Immunol 1994; 94:583-93.
35. Kobayashi T, Hashimoto S, Imai K et al. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin Exp Allergy 1994; 96:110-15.
36. Gosset P, Tillie-Leblond I, Janin A et al. Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int Arch Allergy Appl Immunol 1995; 106:69-77.
37. Montefort S, Gratziou C, Goulding D et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyteendothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994; 93:1411-21.
38. Shiota Y, Wilson JG, Marukawa M et al. Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of bronchial asthmatics. Chest 1996; 109:94-9.
39. Qu Z, Liebler JM, Powers MR et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995; 147:564-73.
40. de Mora F, Williams CMM, Frenette PS et al. P- and E-selectins are required for the leukocyte recruitment, but not the tissue swelling, associated with IgE- and mast cell-dependent inflammation in mouse skin. Lab Invest 1998; 78:497-505.
41. Furuta G, Schmidt-Choudhury A, Wang MY et al. Mast cell-dependent tumor necrosis factor a production participates in allergic gastric inflammation in mice. Gastroenterology 1997; 113:1560-5.
42. Katayama I, Otoyama K, Yokozeki H, Nishioka K. Effect of mast cell modulators on IgE-mediated murine biphasic cutaneous reactions. Int Arch Allergy Immunol 1996; 109:390-7.
43. Thorlacius H, Raud J, Rosengren-Beezley S et al. Mast cell activation induces P-selectin-dependent leukocyte rolling and adhesion in postcapillary venules in vivo. Biochem Biophys Res Commun 1994; 203:1043-9.
44. Wershil BK, Wang Z-S, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. J Clin Invest 1991; 87:446-53.
45. Kung TT, Stelts DS, Zurcher JA et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol 1995; 12:404-9.
46. Corry DB, Grunig G, Hadeiba H et al. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 1998; 4:344-55.
47. Suto H, Matsuda H, Mitsuishi K et al. NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 1999; 120(Suppl.1): 70-5.
48. van de Rijn M, Mehlhop PD, Judkins A et al. A murine model of allergic rhinitis: studies on the role of IgE in pathogenesis and analysis of the eosinophil influx elicited by allergen and eotaxin. J Allergy Clin Immunol 1998; 102:65-74.
49. Brusselle G, Kips J, Joos G et al. Allergen-induced airway inflammation and bronchial responsiveness in wild type and interleukin-4-deficient mice. Am J Respir Cell Mol Biol 1995; 12:254-9.
50. Gleich GJ, Kita H. Bronchial asthma: lessons from murine models. Proc Natl Acad Sci USA 1997; 94:2101-2.
51. Korsgren M, Erjefalt JS, Korsgren O et al. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997; 185:885-92.
52. Johnson JR, Wiley RE, Fattouh R et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med 2004; 169:378-85.
53. Durand B, Migliaccio G, Yee NS et al. Long-term generation of human mast cells in serum-free cultures of CD34+ cord blood cells stimulated with stem cell factor and interleukin-3. Blood 1994; 84:3667-74.
54. Nilsson G, Blom T, Kusche-Gullberg M et al. Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 1994; 39:489-98.
55. 1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin. Allergy 1994; 49:246-53.
56. Yano K, Yamaguchi M, de Mora F et al. Production of macrophage inflammatory protein-1a by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE binding ability. Lab Invest 1997; 77:185-93.
57. Yamaguchi M, Lantz CS, Oettgen HC et al. IgE enhances mouse mast cell FceRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997; 185:663-72.
58. Kallos P, Kallos L. Experimental asthma in guinea-pigs revisited. Int Arch Allergy Immunol 1984; 73:77-85.
59. Minshall E, Sanjar S. The sensitized guinea pig as a model of allergic asthma. In: Allergy and Allergic Diseases (Kay AB, ed.), Vol. 2. Oxford: Blackwell Science, 1997; 1093-102.
60. Gundel RH, Wegner CD, Torcellini CA et al. Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys. J Clin Invest 1991; 88:1407-11.
61. Abraham WM, Gill A, Ahmed A et al. A small-molecule, tight-binding inhibitor of the integrin alpha(4)beta(1) blocks antigen-induced airway responses and inflammation in experimental asthma in sheep. Am J Respir Crit Care Med 2000; 162:603-11.
62. Bosse J, Boileau R, Begin R. Chronic allergic airway disease in the sheep model; functional and lung-lavage features. J Allergy Clin Immunol 1987; 79:339-44.
63. Reedy LM, Miller WH Jr, Willemse T. Allergic Skin Diseases of Dogs and Cats. Philadelphia: W.B. Saunders, 1997.
64. Willemse T. Comparative aspects of canine and human atopic dermatitis. Semin Vet Med Surg (Small Anim) 1988; 3:255 (Letter).
65. Rhodes KH, Kerdel F, Soter NA. Comparative aspects of canine and human atopic dermatitis. Semin Vet Med Surg (Small Anim) 1987; 2:166-72.
66. Queralt M, Brazis P, Merlos M, Puigdemont A. Inhibitory effects of rupatadine on mast cell histamine release and skin wheal development induced by Ascaris suum in hypersensitive dogs. Drug Dev Res 1998; 44:49-55.
67. Hirshman CA. The Basenji-greyhound dog model of asthma. Chest 1985; 87:S172-8.
68. Hirshman CA, Downes H, Veith L. Airway responses in offspring of dogs with and without airway hyperreactivity. J Appl Physiol 1984; 56:1272-7.
69. Butler JM, Peters JE, Hirshman CA et al. Pruritic dermatitis in asthmatic Basenji-greyhound dogs: a model for human atopic dermatitis. J Am Acad Dermatol 1983; 8:33-8.
70. Emala C, Hirshman CA. Canine models of asthma and hyperresponsiveness. In: Allergy and Allergic Diseases (Kay AB, ed.), Vol 2. Oxford: Blackwell Science, 1997; 1103-10.
71. Schwartzman RM, Massicot JG, Sogn DD, Cohen SG. The atopic dog model: report of an attempt to establish a colony. Int Arch Allergy Appl Immunol 1983; 72:97-101.
72. Ermel RW, Kock M, Griffey SM et al. The atopic dog: a model for food allergy. Lab Anim Sci 1997; 47:40-9.
73. Jiang H, Rao K, Halayko AJ et al. Bronchial smooth muscle mechanics of a canine model of allergic airway hyperresponsiveness. J Appl Physiol 1992; 72:39-45.
74. Turner CR, Kolbe J, Spannhake EW. Rapid increase in mast cell numbers in canine central and peripheral airways. J Appl Physiol 1988; 65:445-51.
75. 2-receptors. Adv Pharmacol Chemother 1980; 17:103-31.
76. Patterson R. Investigation of spontaneous hypersensitivity of the dog. J Allergy 1960; 31:351-63.
77. Becker AB, Hershkovich J, Simons FER et al. Development of chronic airway hyperresponsiveness in ragweed-sensitized dogs. J Appl Physiol 1989; 66:2691-7.
78. Patterson R, Roberts M, Pruzansky JJ. Comparison of reaginic antibodies from three species. J Immunol 1969; 102:466-75.
79. de Weck AL, Mayer P, Stumper B et al. Dog allergy, a model for allergy genetics. Int Arch Allergy Immunol 1997; 113:55-7.
80. Tse KS, Kepron W, Sehon AH. A canine model for the study of allergic asthma and suppression of hapten-specific IgE antibody response. Monogr Allergy 1979; 14:38-44.
81. Baker AP, Krell RD, Spicer SS, Chakrin LW. Histochemical and biochemical evaluation of complex carbohydrates in respiratory tissue of a canine model of allergic asthma. Exp Mol Pathol 1979; 31:284-96.
82. Kepron W, James JM, Kirk B et al. A canine model for reaginic hypersensitivity and allergic bronchoconstriction. J Allergy Clin Immunol 1977; 59:64-9.
83. Calonico LD, Phillips MJ, McDonald DM, Gold WM. An ultrastructural analysis of dog mastocytoma cells and normal mast cells. Anat Rec 1985; 212:399-407.
84. Caughey GH, Viro NF, Calonico LD et al. Chymase and tryptase in dog mastocytoma cells: asynchronous expression as revealed by enzyme cytochemical staining. J Histochem Cytochem 1988; 36:1053-60.
85. de Mora F, Garcia G, Ferrer L, Arboix M. Canine cutaneous mast cells dispersion and histamine secretory characterization. Vet Immunol Immunopathol 1993; 39:421-9.
86. DeVinney R, Gold WM. Establishment of two dog mastocytoma cell lines in continuous culture. Am J Respir Cell Mol Biol 1990; 3:413-20.
87. Lazarus SC, DeVinney R, McCabe LJ et al. Isolated canine mastocytoma cells: propagation and characterization of two cell lines. Am J Physiol 1986; 251:C935-44.
88. Pennington DW, Ruoss SJ, Gold WM. Dog mastocytoma cells secrete a growth factor for fibroblasts. Am J Respir Cell Mol Biol 1992; 6:625-32.
89. Thomas PS, Schreck RE, Ruoss SJ, Lazarus SC. Heterogeneity of intact granules purified from canine mastocytoma cell lines. Am J Physiol 1991; 260:L153-60.
90. Kube P, Audige L, Kuther K, Welle M. Distribution, density and heterogeneity of canine mast cells and influence of fixation techniques. Histochem Cell Biol 1998; 110:129-35.
91. Myles AD, Halliwell REW, Ballauf B, Miller HRP. Mast cell tryptase levels in normal canine tissues. Vet Immunol Immunopathol 1995; 46:223-35.
92. Becker AB, Chung KF, McDonald DM et al. Mast cell heterogeneity in dog skin. Anat Rec 1985; 213:477-80.
93. Peeters D, Day MJ, Clercx C. Distribution of leucocyte subsets in bronchial mucosa from dogs with eosinophilic bronchopneumopathy. J Comp Pathol 2005; 133:128-35.
94. Su M, Chi EY, Bishop MJ, Henderson WRJ. Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs. Am Rev Respir Dis 1993; 147:448-56.
95. Bookbinder PF, Butt MT, Harvery HJ. Determination of the number of mast cells in lymph node, bone marrow, and buffy coat cytologic specimens from dogs. J Am Vet Med Assoc 1992; 200:1648-50.
96. Shull RM, Suggs SV, Langley KE et al. Canine stem cell factor (c-kit ligand) supports the survival of hematopoietic progenitors in long term canine marrow culture. Exp Hematol 1992; 20:1118-24.
97. Szabo A, Boros M, Kaszaki J, Nagy S. The role of mast cells in mucosal permeability changes during ischemia-reperfusion injury in the small intestine. Clin Exp Allergy 1997; 27:972-7.
98. Soll AH, Toomey M, Culp D et al. Modulation of histamine release from canine fundic mucosal mast cells. Am J Physiol 1988; 254:G40-8.
99. Auchampach JA, Jin X, Wan TC et al. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2b receptor. Mol Pharmacol 1997; 52:846-60.
100. Ennis M, Amon EU, Lorenz W. Histamine release from canine lung and liver mast cells induced by radiographic contrast media. Agents Actions 1989; 27:101-3.
101. Frangogiannis NG, Lindsey ML, Michael LH et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 1998; 98:699-710.
102. Matsumoto I, Inoue Y, Shimada T, Aikawa T. Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs. J Exp Med 2001; 194:71-8.
103. Morimoto M, Tsujimura T, Kanamura Y et al. Expression of c-kit and stem cell factor mRNA in liver specimens from healthy adult dogs. Am J Vet Res 1998; 59:363-6.
104. Yamamoto K. Electron microscopy of mast cells in the venous wall of canine liver. J Vet Med Sci 2000; 62:1183-8.
105. Takahashi T, Kitani S, Nagase M et al. IgG-mediated histamine release from canine mastocytoma-derived cells. Int Arch Allergy Immunol 2001; 25:228-35.
106. Galli SJ. New insights into 'The riddle of the mast cells': microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990; 62:5-33.
107. Garcia G, Brazis P, Majo N et al. Comparative morphofunctional study of dispersed mature canine cutaneous mast cells and BR cells, a poorly differentiated mast cell line from a dog subcutaneous mastocytoma. Vet Immunol Immunopathol 1998; 62:323-37.
108. Gordon JR, Galli SJ. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 1991; 174:103-7.
109. Goetzl EJ, Phillips MJ, Gold WM. Stimulus specificity of the generation of leukotrienes by dog mastocytoma cells. J Exp Med 1983; 158:731-7.
110. Benyon RC, Robinson C, Church MK. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol 1989; 97:898-904.
111. Welle MM, Olivry T, Grimm S, Suter M. Mast cell density and subtypes in the skin of dogs with atopic dermatitis. J Comp Pathol 1999; 120:187-97.
112. Brazís P, de Mora F, Ferrer L, Puigdemont A. IgE enhances Fc epsilon RI expression and IgE-dependent TNF-alpha release from canine skin mast cells. Vet Immunol Immunopathol 2002; 85:205-12.
113. Brazís P, Torres R, Queralt M et al. Evaluation of cell surface IgE receptors on the canine mastocytoma cell line C2 maintained in continuous culture. Am J Vet Res 2002; 63:763-6.
114. London CA, Kisseberth WC, Galli SJ et al. Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumors. J Comp Pathol 1996; 115:399-414.
115. Denburg JA, Inman MD, Wood L et al. Bone marrow progenitors in allergic airways diseases: studies in canine and human models. Int Arch Allergy Immunol 1997; 113:181-3.
116. Reguera MJ, Rabanal RM, Puigdemont A, Ferrer L. Canine mast cell tumors express stem cell factor receptor. Am J Dermatopathol 2000; 22:49-54.
117. Nakamura R, Sato Y, Takagi K et al. Presence and primary sequence of a high affinity IgG receptor on canine mastocytoma (CM-MC) cells. Immunogenetics 2003; 55:271-4.
118. Kirshenbaum AS, Akin C, Wu Y et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FceRI or FccRI. Leuk Res 2003; 27:677-82.
119. Mori K, Shibano M, Satoh H et al. Differential response of mast cells separated from various organs and basophils of dogs to the fluoroquinolone antimicrobial levofloxacin. Arch Toxicol 2001; 75:227-33.
120. Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 1997; 99:155-60.
121. Enerbäck L. Mast cells in the gastrointestinal mucosa II. Dye binding metachromatic properties. Acta Pathol Microbiol Scand 1966; 66:303-12.
122. Osborne ML, Sommerhoff CP, Nadel JA, McDonald D. Histochemical comparison of mast cells obtained from the airways of mongrel dogs and Basenji-greyhound dogs by bronchoalveolar lavage. Am Rev Respir Dis 1989; 140:749-55.
123. Irani AM, Schwartz LB. Human mast cell heterogeneity. Allergy Proc 1994; 15:303-8.
124. Schechter NM, Slavin D, Fetter RD et al. Purification and identification of two serine class proteinases from dog mast cells biochemically and immunologically similar to human proteinases tryptase and chymase. Arch Biochem Biophys 1988; 262:232-44.
125. Noviana D, Mamba K, Makimura S, Horii Y. Distribution, histochemical and enzyme histochemical characterization of mast cells in dogs. J Mol Histol 2004; 35:123-32.
126. Becker AB, Chung KF, McDonald DM et al. Cutaneous mast cell heterogeneity: response to antigen in atopic dogs. J Allergy Clin Immunol 1986; 78:937-42.
127. Lawrence ID, Warner JA, Cohan VL et al. Purification and characterization of human skin mast cells. J Immunol 1987; 169:3062-9.
128. Benyon RC, Lowman MA, Church MK. Human skin mast cells: their dispersion, purification, and secretory characterization. J Immunol 1987; 138:861-7.
129. Nimmo Wilkie JS, Yager JA, Eyre P, Parker WM. Morphometric analyses of the skin of dogs with atopic dermatitis and correlations with cutaneous and plasma histamine and total serum IgE. Vet Pathol 1990; 27:179-86.
130. Queralt M, Merlos M, Giral M, Puigdemont A. Dual effect of a new compound, rupatadine, on edema induced by platelet-activating factor and histamine in dogs: comparison with antihistamines and PAF antagonists. Drug Dev Res 1996; 39:12-18.
131. Masini E, Fantozzi R, Conti A et al. Immunological modulation of cholinergic histamine release in isolated rat mast cells. Agents Actions 1985; 16:152-4.
132. Forsberg LS, Lazarus SC, Seno N et al. Dog mastocytoma proteoglycans: occurrence of heparin and oversulfated chondroitin sulfates, containing trisulfated disaccharides in three cell lines. Biochem Biophys Acta 1988; 967:416-28.
133. Caughey GH, Zerweck EH, Vanderslice P. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J Biol Chem 1991; 15:12956-63.
134. Kunori Y, Muroga Y, Iidaka M et al. Species differences in angiotensin II generation and degradation by mast cell chymases. J Recept Signal Transduct Res 2005; 25:35-44.
135. Nadel JA. Roles of mast cell proteases in airways. Drugs 1989; 37(Suppl. 1): 51-5.
136. Johnson PR, Ammit AJ, Carlin SM et al. Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus. Eur Respir J 1997; 10:38-43.
137. Gold WM, Lazarus SC. Mast cells and cell-to-cell interactions in airways. Am Rev Respir Dis 1991; 143:S61-3.
138. Noviana D, Harjanti W, Otsuka Y, Horii Y. Proliferation of protease-enriched mast cells in sarcoptic skin lesions of raccoon dogs. J Comp Pathol 2004; 131:28-37.
139. Stewart JA Jr, Wei CC, Brower GL et al. Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in dog. J Mol Cell Cardiol 2003; 35:311-19.
140. Raymond WW, Sommerhoff CP, Caughey GH. Mastin is a gelatinolytic mast cell peptidase resembling a mini-proteasome. Arch Biochem Biophys 2005; 435:311-22.
141. Wolters PJ, Raymond WW, Blount JL, Caughey GH. Regulated expression, processing and secretion of dog mast cell dipeptidyl peptidase l. J Biol Chem 1998; 273:15514-20.
142. Robinson C, Benyon C, Holgate ST, Church MK. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells. J Invest Dermatol 1989; 93:397-404.
143. Thomas PS, Wilson AN, Schreck RE et al. Prostaglandin H synthase within canine mast cell granule. Am J Physiol 1992; 263:L168-76.
144. Gueck T, Aschenbach JR, Fuhrmann H. Influence of vitamin E on mast cell mediator release. Vet Dermatol 2002; 13:301-5.
145. 2 release from isolated canine gastric mucosal mast cells. Dig Dis Sci 1999; 44:1384-9.
146. Gueck T, Seidel A, Fuhrmann H. Consequences of eicosapentaenoic acid (n-3) and arachidonic acid (n-6) supplementation on mast cell mediators. J Anim Physiol Anim Nutr (Berl) 2004; 88:259-65.
147. Thomsen MK, Kristensen F, Elling F. Species-specificity in the generation of eicosanoids: emphasis on leukocyte-activating factors in the skin of allergic dogs and humans. In: Advances in Veterinary Dermatology (Ihrke PJ, Mason IS, White SD, eds). Oxford: Pergamon Press, 1993; 63-78.
148. Phillips MJ, Gold WM, Goetzl EJ. IgE-dependent and ionophore-induced generation of leukotrienes by dog mastocytoma cells. J Immunol 1983; 131:906-10.
149. Becker AB, Black C, Lilley MK et al. Antiasthmatic effects of a leukotriene biosynthesis inhibitor (MK-0591) in allergic dogs. J Appl Physiol 1995; 78:615-22.
150. Matsumoto T, Ashida Y. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane A2 receptor antagonist (AA-2414) in Ascaris suum-allergic dogs. Prostaglandins 1993; 46:301-18.
151. Thomas PS, Pennington DW, Schreck RE et al. Authentic 17 kDa tumour necrosis factor alpha is synthesized and released by canine mast cells and up-regulated by stem cell factor. Clin Exp Allergy 1996; 26:710-18.
152. Torres R, de Castellarnau C, Ferrer LL et al. Mast cells induce upregulation of P-selectin and intercellular adhesion molecule 1 on carotid endothelial cells in a new in vitro model of mast cell to endothelial cell communication. Immunol Cell Biol 2002; 80:170-7.
153. Brazís P, Queralt M, de Mora F et al. Stem cell factor enhances IgE-mediated histamine and TNF-alpha release from dispersed canine cutaneous mast cells. Vet Immunol Immunopathol 2000; 75:97-108.
154. Hammerberg B, Olivry T, Ortoin S. Skin mast cell histamine release following stem cell factor and high affinity immunoglobulin E receptor cross-linking in dogs with atopic dermatitis. Vet Dermatol 2001; 12:339-46.
155. Columbo M, Horowitz EM, Botana LM et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992; 149:599-608.
156. Cheng Chew SB, Leung PY. Localisation of VIP- and CGRP-like substances in the skin and sinus hair follicles of various mammalian species. Histochem Cell Biol 1996; 105:443-52.
157. Crockett-Tobari E, Fantone JC. L-selectin stimulation of canine neutrophils initiates calcium signal secondary to tyrosine kinase activation. Am J Physiol 1997; 272:H1302-8.
158. Hawkins HK, Entman ML, Zhu JY et al. Acute inflammatory reaction after myocardial ischemic injury reperfusion. Am J Pathol 1996; 148:1957-69.
159. Sinke JD, Rutten VPMG, Willemse T. IL4 production by mast cells in the skin of dogs with atopic dermatitis. Vet Dermatol 2000; 11(Suppl. 1): 32 (Abstract).
160. Pennington DW, Lopez AR, Thomas PS et al. Dog mastocytoma cells produce transforming growth factor b1. J Clin Invest 1992; 90:35-41.
161. Brazis P, Queralt M, de Mora F et al. Comparative study of histamine release from skin mast cells dispersed from atopic Ascaris-sensitive and healthy dogs. Vet Immunol Immunopathol 1998; 66:43-51.
162. Tunon de Lara JM, Okayama Y, Savineau J-P, Marthan R. IgE-induced passive sensitization of human isolated bronchi and lung mast cells. Eur Respir J 1995; 8:1861-5.
163. Brzezinska-Blaszczyk E, Zalewska A. Sensitivity of cutaneous mast cells to anaphylactic and nonimmunological stimuli. Arch Immunol Ther Exp 1997; 45:55-9.
164. de Paulis A, Marino I, Ciccarelli A et al. Human synovial mast cells: ultrastructural in situ and in vitro immunologic characterization. Arthritis Rheum 1996; 39:1222-33.
165. Igarashi Y, Kurosawa M, Ishikawa O et al. Characteristics of histamine release from cultured human mast cells. Clin Exp Allergy 1996; 26:587-602.
166. Patella V, Marino I, Lamparter B et al. Immunologic and nonimmunologic release of histamine and tryptase from human heart mast cells. Inflamm Res 1995; 44:S22-3.
167. Patella V, Marino I, Lamparter B et al. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol 1995; 154:2855-65.
168. Amon U, Nitschke M, Dieckmann D et al. Activation and inhibition of mediator release from skin mast cells: a review of in vitro experiments. Clin Exp Allergy 1994; 24:1098-104.
169. Tainsh KR, Liu WL, Lau HY et al. Mast cell heterogeneity in man: unique functional properties of skin mast cells in response to a range of polycationic stimuli. Immunopharmacology 1992; 24:171-80.
170. Ennis M, Pearce FL. Differential reactivity of isolated mast cells from the rat and the guinea pig. Eur J Pharmacol 1980; 66:339-45.
171. 1-antihistamines on histamine release from dispersed canine cutaneous mast cells. Am J Vet Res 1997; 58:293-7.
172. Church MK, Pao GJ-K, Holgate ST. Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J Immunol 1982; 129:2116-21.
173. Sommerhoff CP, Osborne ML, Gold WM, Lazarus SC. Functional and morphologic characterization of mast cells recovered by bronchoalveolar lavage from Basenji greyhound and mongrel dogs. J Allergy Clin Immunol 1989; 83:441-9.
174. Scholzen T, Armstrong CA, Bunnett NW et al. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998; 7:81-96.
175. Lowman MA, Rees PH, Benyon RC, Church MK. Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 1988; 81:590-7.
176. Linden J, Auchampach JA, Jin X, Figler RA. The structure and function of A1 and A2B adenosine receptors. Life Sci 1998; 62:1519-24.
177. Okayama Y, Church MK. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int Arch Allergy Immunol 1992; 97:216-25.
178. Togias AG, Proud D, Kagey-Sobotka A et al. In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease. Ann Allergy 1989; 63:465-9.
179. Bousquet J, Hejjaoui A, Clauzel AM et al. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 1988; 82:881-7.
180. Queralt M, Brazis P, Merlos M et al. In vitro inhibitory effect of rupatadine on histamine and TNF-alpha release from dispersed canine skin mast cells and the human mast cell line HMC-1. Inflamm Res 2000; 49:355-60.
181. Church MK, Gradidge CF. Inhibition of histamine release from human lung by antihistamines and related drugs. Br J Pharmacol 1980; 69:663-7.
182. Rimmer SJ, Church MK. The pharmacology and mechanisms of action of histamine H1-antagonists. Clin Exp Allergy 1990; 20:3-17.
183. Garcia G, Ferrer L, de Mora F, Puigdemont A. Inhibition of histamine release from dispersed canine skin mast cells by cyclosporin A, rolipram and salbutamol, but not by dexamethasone or sodium cromoglycate. Vet Dermatol 1998; 9:81-6.
184. Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987; 9:421-9.
185. Sommerhoff CP, Osborne ML, Lazarus SC. Effect of inhibitors on histamine release from mast cells recovered by bronchoalveolar lavage in Basenji-greyhound and mongrel dogs. Agents Actions 1990; 31:183-9.
186. Leung KBP, Flint KC, Brostoff J et al. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Thorax 1988; 43:756-61.
187. Ting S, Weiman B, Lavker R. Cromolyn does not modulate human allergic skin reactions in vivo. J Allergy Clin Immunol 1983; 71:12-17.
188. Kelly K, Spooner CH, Rowe BH. Nedocromil sodium vs. sodium cromoglycate for preventing exercise-induced bronchoconstriction in asthmatics. Cochrane Database Syst Rev 2000; 4:CD002731.
189. Cohan VL, Undem BJ, Fox CC et al. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine and skin. Am Rev Respir Dis 1989; 140:951-4.
190. Soll AH, Toomey M. Beta-adrenergic and prostanoid inhibition of canine fundic mucosal mast cells. Am J Physiol 1989; 256:G727-32.
191. Vieytes MR, Louzao MC, de la Cruz LF, Botana LM. Efecto del isoproterenol sobre la liberacion de histamina en mastocitos de pulmon de rata. Rev Esp Fisiol 1991; 47:13-18.
192. Hanifin JM, Chan SC, Cheng JB et al. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 1996; 107:51-6.
193. Ferrer L, Alberola J, Queralt M et al. Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis. Vet Rec 1999; 145:191-4.
194. Stellato C, de Paulis A, Ciccarelli A et al. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol 1992; 98:800-4.
195. Cirillo R, Triggiani M, Siri L et al. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J Immunol 1990; 144:3891-7.
196. Church MK, El-Lati S, Caulfield JP. Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol 1991; 94:310-18.
197. Mousli M, Hugli TE, Landry Y, Bronner C. Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacology 1994; 27:1-11.
198. Rafael J, Gorospe M, Tharp M et al. Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis. Neuromuscul Disord 1994; 4:325-33.
199. Somasundaram P, Ren G, Nagar H et al. Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J Pathol 2005; 205:102-11.
200. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381:75-7.
201. Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992; 258:1957-9.
202. Yakabi K, Arimura T, Koyanagi M et al. Effects of interleukin-8 and Helicobacter pylori on histamine release from isolated canine gastric mucosal mast cells. J Gastroenterol 2002; 37:70-2.
203. Wittich FW. Spontaneous allergy (atopy) in the lower animal: seasonal hay fever (fall type) in a dog. J Allergy 1940; 12:247-51.
204. Scott DW, Miller WH Jr, Griffin CE. Muller and Kirk's Small Animal Dermatology. Philadelphia: W.B. Saunders, 2001.
205. de Mora F, Ferrer L. Dermatitis atopica canina: un posible modelo de estudio de la dermatitis atopica humana? Piel 1994; 9:16-26.
206. Griffin CE, DeBoer DJ. The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis. Vet Immunol Immunopathol 2001; 81:255-69.
207. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995; 96:302-19.
208. Olivry T, Moore PF, Affolter VK, Naydan DN. Langerhans cell hyperplasia and IgE expression in canine atopic dermatitis. Arch Dermatol Res 1996; 288:579-85.
209. Olivry T, Naydan DK, Moore PF. Characterization of the cutaneous inflammatory infiltrate in canine atopic dermatitis. Am J Dermatopathol 1997; 19:477-86.
210. Sinke JD, Thepen T, Bihari IC et al. Immunophenotyping of skin-infiltrating T-cell subsets in dogs with atopic dermatitis. Vet Immunol Immunopathol 1997; 57:13-23.
211. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003; 112(Suppl. 6): S128-39.
212. Halliwell REW, Kunkle GA. The radioallergosorbent test in the diagnosis of canine atopic disease. J Allergy Clin Immunol 1978; 62:236-42.
213. Sousa CA. Atopic dermatitis. Vet Clin North Am Small Anim Pract 1988; 18:1049-59.
214. Bevier DE. Long-term management of atopic disease in the dog. Vet Clin North Am Small Anim Pract 1990; 20:1487-507.
215. Olivry T, Sousa CA. The ACVD task force on canine atopic dermatitis (XIX): general principles of therapy. Vet Immunol Immunopathol 2001; 81:311-16.
216. Olivry T, Dean GA, Tompkins MB et al. Toward a canine model of atopic dermatitis: amplification of cytokine gene transcripts in the skin of atopic dogs. Exp Dermatol 1999; 8:204-11.
217. Reiss TF, Rubinstein I, Emery DL et al. Local mediator release after antigen challenge of a bronchial segment in allergic dogs. Am J Physiol 1989; 257:L366-72.
218. Becker AB, Chung KF, McDonald DM et al. Cutaneous allergic response in atopic dogs: relationship of cellular and histamine responses. J Allergy Clin Immunol 1988; 81:441-8.
219. Hirshman CA, Leu DB, Austin DR et al. Elevated mononuclear leukocyte phosphodiesterase in allergic dogs with and without airway hyperresponsiveness. J Allergy Clin Immunol 1987; 79:46-53.
220. Misawa M, Ohmori S, Yanaura S. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on bronchial and cutaneous allergic responses to Ascaris in dogs. Arzneimittelforschung 1986; 36:1647-50.
221. Lewis AJ, Kirchner T, Dervinis A, Rosenthale ME. Ascaris-induced allergic asthma in the conscious dog: a model for the pharmacologic modulation of immediate type hypersensitivity. J Pharmacol Methods 1982; 7:35-46.
222. Grant BJ, Fortune JB, West JB. Effect of local antigen inhalation and hypoxia on lobar blood flow in allergic dogs. Am Rev Respir Dis 1980; 122:39-46.
223. Egli KS, Schiessl B, Roosje PJ et al. Evaluation of the usefulness of sensitization to aeroallergens as a model for canine atopic dermatitis in genetically predisposed beagles. Am J Vet Res 2002; 63:1329-36.
224. Helm RM. Food allergy animal models: an overview. Ann N Y Acad Sci 2002; 964:139-50.
225. Chung KF, Osborne ML, Corrales RJ et al. Histamine release and circulating cells after antigen inhalation in allergic dogs. J Appl Physiol 1987; 62:253-8.
226. Gold WM, Meyers GL, Dain DS et al. Changes in airway mast cells and histamine caused by antigen aerosol in allergic dogs. J Appl Physiol 1977; 43:271-5.
227. Lazarus SC, McCabe LJ, Nadel JA et al. Effects of mast cell-derived mediators on epithelial cells in canine trachea. Am J Physiol 1986; 251:C387-94.
228. Leff AR, Stimler NP, Munoz NM et al. Augmentation of respiratory mast cell secretion of histamine caused by vagus nerve stimulation during antigen challenge. J Immunol 1986; 136:1066-73.
229. Varsano S, Lazarus SC, Gold WM, Nadel JA. Selective adhesion of mast cells to tracheal epithelial cells in vitro. J Immunol 1988; 140:2184-92.
230. Hirshman CA, Austin DA, Kettelkamp NS. Enhanced bronchoalveolar lavage mast cells histamine releasability in allergic dogs with and without airway hyperresponsiveness. J Allergy Clin Immunol 1988; 81:829-35.
231. Turner CR, Darowski MJ, Sampson HA et al. Dermal mast cell releasability and end organ responsiveness in atopic and nonatopic dogs. J Allergy Clin Immunol 1989; 83:643-8.
232. Misawa M, Takenouchi K, Shirakawa Y, Yanaura S. Effects of mast cell stabilizers on a new bronchial asthma model using compound 48/80 in dogs. Jpn J Pharmacol 1987; 44:197-205.
233. Wuersch K, Brachelente C, Doherr M et al. Immune dysregulation in flea allergy dermatitis - a model for the immunopathogenesis of allergic dermatitis. Vet Immunol Immunopathol 2006; 110:311-23.
234. Torres R, Grifols J, Fondevila D, de Mora F. Dermal exposure to Ag induces sensitization and inflammation, in addition to the immediate response, in the Ascaris suum-hypersensitive dog model of skin allergy. XXII Congress of the European Academy of Allergology and Clinical Immunology (EAACI), June 2003; 58(Suppl. 74): 262 (Abstract).
235. Halliwell REW, Schwartzman RM, Rockey JH. Antigenic relationship between human IgE and canine IgE. Clin Exp Immunol 1972; 10:399-402.
236. Day MJ, Corator A. Subclass profile of allergen-specific IgG antibodies in atopic dogs. Res Vet Sci 1996; 61:136-42.
237. Willemse A, Noordzij A, van den Brom WE, Rutten VPMG. Allergen specific IgGd antibodies in dogs with atopic dermatitis as determined by the enzyme linked immunosorbent assay (ELISA). Clin Exp Immunol 1985; 59:359-63.
238. Willemse A, Noordzij A, Rutten VPMG, Bernadina WE. Induction of non-IgE anaphylactic antibodies in dogs. Clin Exp Allergy 1985; 59:351-8.
239. Hammerberg B, Bevier D, DeBoer DJ et al. Auto IgG anti-IgE and IgG X IgE immune complex presence and effects on ELISA-based quantitation of IgE in canine atopic dermatitis, demodectic acariasis and helminthiasis. Vet Immunol Immunopathol 1997; 60:33-46.
240. Scott DW. Observations on canine atopy. J Am Anim Hosp Assoc 1981; 17:91-100.
241. Ordeix L, Fondevila D, de Mora F et al. Assesssment of the proliferative activity of canine dermal mast cells by BrDU and proliferating cell nuclear antigen labelling. Vet Dermatol 2001; 12:321-5.
242. Auxilia ST, Hill PB. Mast cell distribution, epidermal thickness and hair follicle density in normal canine skin: possible explanations for the predilection sites of atopic dermatitis? Vet Dermatol 2000; 11:247-54.
243. de Mora F, Garcia G, Puigdemont A et al. Skin mast cell releasability in dogs with atopic dermatitis. Inflamm Res 1996; 45:424-7.
244. Jackson HA, Miller HR, Halliwell RE. Canine leucocyte histamine release: response to antigen and to anti-IgE. Vet Immunol Immunopathol 1996; 53:195-206.
245. Djukanovic R, Lai CK, Wilson JW et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992; 5:538-44.
246. Horsmanheimo L, Harvima IT, Jarvikallio A et al. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994; 131:348-53.
247. Saarinen JV, Harvima RJ, Naukkarinen A et al. Interleukin-4-positive mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin. Allergy 2001; 56:58-64.